Danaher Corporation (ETR: DAP)
Germany
· Delayed Price · Currency is EUR | Market Cap | 157.34B |
| Revenue (ttm) | 21.27B |
| Net Income (ttm) | 3.49B |
| Shares Out | n/a |
| EPS (ttm) | 4.70 |
| PE Ratio | 45.13 |
| Forward PE | n/a |
| Dividend | 0.96 (0.43%) |
| Ex-Dividend Date | Dec 27, 2024 |
| Volume | 838 |
| Open | 217.00 |
| Previous Close | 219.75 |
| Day's Range | 214.75 - 218.30 |
| 52-Week Range | 204.90 - 260.00 |
| Beta | 0.86 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 28, 2025 |
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and service... [Read more]
Financial Performance
In 2023, Danaher's revenue was $23.89 billion, a decrease of -10.33% compared to the previous year's $26.64 billion. Earnings were $4.74 billion, a decrease of -33.23%.
Financial numbers in USD Financial StatementsNews
Danaher, Cryoport, Sartorius win Buy as Guggenheim expands bioprocessing coverage
3 of the Best Companies to Own in 2025 and Beyond
#Morningstar #BestStockstoInvestIn #StockInvesting These companies have durable competitive advantages and generate reliable cash flows. 00:00 Introduction 00:46 Danaher DHR 01:36 Paychex PAYX 02:17 ...
Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value
Concentrate on a select few high-conviction stocks across different sectors to avoid "diworsification" and maximize returns, inspired by Charlie Munger and Warren Buffett. Utilize Joel Greenblatt's "M...
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst
BofA Securities reports that the Life Sciences Tools sector struggled in fiscal year 2024.
Danaher Corp (DHR) Announces Quarterly Dividend
Danaher Corp (DHR) Announces Quarterly Dividend
Danaher Announces Quarterly Dividend
WASHINGTON , Dec. 10, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common s...
Danaher: A Resilient And Solid Company With Growth Potential
Danaher Corporation (DHR) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
Navigating Market Uncertainty: Intrinsic Value of Danaher Corp
Navigating Market Uncertainty: Intrinsic Value of Danaher Corp
Danaher to Present at Evercore ISI HealthCONx Conference
WASHINGTON , Nov. 26, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conf...
What the Options Market Tells Us About Danaher
Investors with a lot of money to spend have taken a bearish stance on Danaher (NYSE: DHR). And retail traders should know. We noticed this today when the trades showed up on publicly available option...
Revving Up: 2 Underperforming Dividend Giants Ready To Outshine
Two dividend stocks are well-positioned for growth after adapting to challenges. Find out why CP and DHR offer solid returns and potential for a strong rebound.
Unlocking Intrinsic Value: Analysis of Danaher Corp
Unlocking Intrinsic Value: Analysis of Danaher Corp
Brett Girard's Past Picks: Fairfax, TC Energy and Danaher
Brett Girard, chief financial officer and portfolio manager at Liberty International Investment Management, discusses his past picks: Fairfax, TC Energy and Danaher
Peering Into Danaher's Recent Short Interest
Danaher's (NYSE: DHR) short percent of float has fallen 5.68% since its last report. The company recently reported that it has 5.32 million shares sold short , which is 0.83% of all regular shares th...
Inquiry Into Danaher's Competitor Dynamics In Life Sciences Tools & Services Industry
In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In this article, we will conduct an extensive ...
A Look Into Danaher Inc's Price Over Earnings
In the current market session, Danaher Inc. (NYSE: DHR) share price is at $242.91, after a 0.09% spike. Moreover, over the past month, the stock decreased by 8.25% , but in the past year, went up by ...
Danaher upgraded to outperform by Wolfe, recent stock drop cited
Wolfe has upgraded Danaher (DHR) to outperform from peer perform, citing a recent drop in the share price. Read more here.
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,600 Today
Danaher (NYSE: DHR) has outperformed the market over the past 10 years by 5.16% on an annualized basis producing an average annual return of 16.37%. Currently, Danaher has a market capitalization of ...
Understanding Danaher's Cautiousness
Danaher reported okay Q3 earnings, with "cautiousness" probably being the best adjective to describe the release. The company has finally returned to growth and forward-looking commentary seems positi...
Decoding Danaher Corp (DHR): A Strategic SWOT Insight
Decoding Danaher Corp (DHR): A Strategic SWOT Insight
Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating
On Tuesday, Danaher Corp (NYSE: DHR) reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion . Guidance: Danaher reaffirms that in fiscal year 2024...
Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating
On Tuesday, Danaher Corp DHR reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion.
Danaher returns a key business to growth, and we're raising our stock rating back to buy
Danaher's stock drop presents a buying opportunity. We're also increasing our price target.
A Closer Look at Danaher's Options Market Dynamics
Deep-pocketed investors have adopted a bearish approach towards Danaher (NYSE: DHR), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled th...